Diverse phenotype in patients with complex I deficiency due to mutations in NDUFB11.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 08 04 2018
revised: 23 10 2018
accepted: 09 11 2018
pubmed: 14 11 2018
medline: 7 2 2020
entrez: 14 11 2018
Statut: ppublish

Résumé

Mitochondrial complex I deficiency is the most frequent mitochondrial disorder presenting in childhood and the mutational spectrum is highly heterogeneous. The NDUFB11 gene is one of the recently identified genes, which is located in the short arm of the X-chromosome. Here we report clinical, biochemical, functional and genetic findings of two male patients with lactic acidosis, hypertrophic cardiomyopathy and isolated complex I deficiency due to de novo hemizygous mutations (c.286C > T and c.328C > T) in the NDUFB11 gene. Neither of them had any skin manifestations. The NDUFB11 gene encodes a relatively small integral membrane protein NDUFB11, which is essential for the assembly of an active complex I. The expression levels of this protein was decreased in both patient cells and a lentiviral complementation experiment also supported the notion that the complex I deficiency in those two patients is caused by NDUFB11 genetic defects. Our findings together with a review of the thirteen previously described patients demonstrate a wide spectrum of clinical features associated with NDUFB11-related complex I deficiency. However, histiocytoid cardiomyopathy and/or congenital sideroblastic anemia could be indicative for mutation in the NDUFB11 gene, while the clinical manifestation of the same mutation can be highly variable.

Identifiants

pubmed: 30423443
pii: S1769-7212(18)30265-9
doi: 10.1016/j.ejmg.2018.11.006
pii:
doi:

Substances chimiques

NDUFB11 protein, human 0
Electron Transport Complex I EC 7.1.1.2

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103572

Informations de copyright

Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Auteurs

Karit Reinson (K)

Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Reka Kovacs-Nagy (R)

Institute of Human Genetics, Technische Universität München, Munich, Germany; Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University Budapest, Hungary.

Eve Õiglane-Shlik (E)

Department of Pediatrics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia; Children's Clinic, Tartu University Hospital, Tartu, Estonia.

Sander Pajusalu (S)

Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia.

Margit Nõukas (M)

Estonian Genome Center, University of Tartu, Tartu, Estonia; Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.

Liesbeth T Wintjes (LT)

Radboud Center for Mitochondrial Medicine, Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Frans C A van den Brandt (FCA)

Radboud Center for Mitochondrial Medicine, Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Maaike Brink (M)

Radboud Center for Mitochondrial Medicine, Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Till Acker (T)

Institute of Neuropathology, JL University of Giessen, Giessen, Germany.

Uwe Ahting (U)

Institute of Human Genetics, Technische Universität München, Munich, Germany.

Andreas Hahn (A)

Department of Child Neurology, JL University of Giessen, Giessen, Germany.

Anne Schänzer (A)

Institute of Neuropathology, JL University of Giessen, Giessen, Germany.

Tobias B Haack (TB)

Institute of Human Genetics, Technische Universität München, Munich, Germany; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tuebingen, Germany.

Richard J Rodenburg (RJ)

Radboud Center for Mitochondrial Medicine, Translational Metabolic Laboratory, Department of Pediatrics, Radboud University Medical Center, Nijmegen, the Netherlands.

Katrin Õunap (K)

Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia. Electronic address: katrin.ounap@kliinikum.ee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH